Cerus stock gained 2.63 percent on October 5 as Q2 growth continues
Published on 10/07/2026 at 00:07 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cerus stock gained 2.63 percent to USD 2.34 on Nasdaq on October 5, 2026, while the company reported 10 percent year-over-year growth in second-quarter product revenue. According to Yahoo Finance on July 30, 2026, Cerus also raised its full-year product revenue guidance.
Revenue growth reaches 10 percent
For Q2 2026, product revenue totaled USD 57.4 million, up 10 percent from Q2 2025. Total revenue was USD 63.3 million, while GAAP net loss attributable to Cerus narrowed to USD 2.9 million from USD 5.7 million a year earlier, according to Yahoo Finance on July 30, 2026.
The improvement in the reported loss came alongside positive adjusted EBITDA of USD 3.0 million, marking the ninth consecutive quarter with a positive adjusted EBITDA figure. Operating cash flow remained negative at USD 2.7 million in Q2 2026, keeping cash generation an important counterweight to the revenue trend.
Guidance rises for 2026
Cerus lifted its 2026 product revenue guidance to USD 229 million-USD 231 million from USD 227 million-USD 231 million. IFC revenue guidance also increased to USD 23 million-USD 25 million from USD 22 million-USD 24 million, according to Yahoo Finance.
The company said its INTERCEPT platform remains the core commercial engine for pathogen-reduced blood components. Cerus describes the platelet and plasma systems as globally available, while its red blood cell system remains in late-stage clinical development, according to Cerus Corporation.
Analyst targets remain divided
According to MarketBeat on October 1, 2026, five analysts covered Cerus with three Buy ratings, one Hold rating and one Sell rating. The resulting consensus was Hold, with an average price target of USD 5.25.
Stock trades below yearly high
Cerus stock was last at USD 2.34 on Nasdaq on October 5, 2026, with a 52-week range of USD 1.38 to USD 3.47 and market capitalization of USD 471.6 million. Volume reached 1,595,827 shares in the latest finance quote.
Cerus stock at a glance
- Company: Cerus Corporation
- ISIN: US1570851014
- Ticker: CERS
- Trading venue: Nasdaq
- Price (as of October 5, 2026, 4:00 p.m. ET): USD 2.34
- Market capitalization: USD 471.6 million (as of October 5, 2026)
- 52-week range: USD 1.38-USD 3.47 (as of October 5, 2026)
- Sector / Industry: Healthcare / Medical Devices
More news and analyses on Cerus stock
